Skip to main content
Log in

Methylmalonic and propionic acidurias: Management without or with a few supplements of specific amino acid mixture

  • SSIEM SYMPOSIUM 2005
  • Published:
Journal of Inherited Metabolic Disease

Summary

In a series of 137 patients with methylmalonic acidaemia (MMA) and propionic acidaemia (PA) diagnosed since the early 1970s, we report in more detail 81 patients (51 MMA and 30 PA) diagnosed between 1988 and 2005. In this series, 14% of patients died at initial access revealing the disease before or despite treatment, 18% died later, and the remainder (68%) are still alive. All patients were treated with the same protocol of enteral feeds with a low-protein diet adjusted to individual tolerance, carnitine, antibiotics, and only occasional use of an amino acid (AA) mixture. There was intensive follow-up and monitoring using measurements of urinary urea. Thirty-nine patients with severe forms, followed for more than 3 years, are analysed in particular detail. Of the 17 PA patients, 6 had moderate disability (all neonatal-onset forms), whereas 11 were normal or slightly delayed in their mental development. Four presented with cardiomyopathy, of whom 2 died. Of the 22 MMA patients, 13 presented in the neonatal period, of whom 3 died later, 2 are in renal failure and only 5 are still alive and have a normal or slightly delayed mental development. In the 9 patients with late-onset forms, there were no deaths and all patients but one have normal mental development. Among the 39 patients, only 40% were given an AA supplement at 3 years, and 50% between 6 and 11 years. The actual intake of natural protein was 0.92, 0.78 and 0.77 g/kg per day at 3, 6 and 11 years, respectively, in patients without AA supplementation, whereas it was 0.75, 0.74 and 0.54 g/kg per day in the group who received small quantities of AA (0.4–0.6 g/kg per day). In both groups, feeding disorders were frequent: 55% at 3 years, 35% at 6 years and 12% at 11 years. Many patients were given a food supplement by tube overnight or were even exclusively tube fed: 60% at 3 years, 48% at 6 years and still 27% at 11 years. Growth velocity was near the normal values. Plasma valine and isoleucine were low to very low, as were leucine and phenylalanine but to a lesser extent. Albumin, vitamins, trace elements and markers of bone metabolism were within the normal values. IGF1, 24-hour urine calcium and body mass density were low. Body composition showed a normal to low lean mass and a normal to high fat mass.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AA:

amino acid

BCAA:

branched-chain amino acids

IGF1:

insulin-like growth factor 1

MMA:

methylmalonic acidaemia

MSUD:

maple syrup urine disease

PA:

propionic acidaemia

PKU:

phenylketonuria

PTH:

parathyroid hormone

References

  • Bain MD, Nussey SS, Jones M, Chalmers RA (1995) Use of human somatotrophin in the treatment of a patient with methylmalonic aciduria. Eur J Pediatr 154: 850–852.

    Article  PubMed  CAS  Google Scholar 

  • Baumgartner ER, Viardot C (1995) Long-term follow-up of 77 patients with isolated methylmalonic acidaemia. J Inherit Metab Dis 18: 138–142.

    Article  Google Scholar 

  • Burns SP, Iles RA, Saudubray JM, Chalmers RA (1996) Propionylcarnitine excretion is not affected by metronidazole administration to patients with disorders of propionate metabolism. Eur J Pediatr 155: 31–35.

    PubMed  CAS  Google Scholar 

  • Dhawan A, Mitry RR, Hughes RD (2006) Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis 29: 431–435.

    PubMed  Google Scholar 

  • Dionisi-Vici C, Deodato F, Röschinger W, Rhead WJ, Wilcken B (2006) ‘Classical’ organic acidurias, propionic, methylmalonic and isovaleric acidurias, long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis 29: 383–389.

    PubMed  CAS  Google Scholar 

  • Kelts DG, Ney D, Bay C, Saudubray JM, Nyhan WL (1985) Studies on requirements for amino acids in infants with disorders of amino acid metabolism. I. Effect of alanine. Pediatr Res 51: 86–91.

    Google Scholar 

  • Leonard JV, Daish P, Naughten ER, Bartlett K (1984) The management and long-term outcome of organic acidaemias. J Inherit Metab Dis 7(Supplement 1): 13–17.

    Article  PubMed  Google Scholar 

  • Marsden D, Barshop BA, Capistrano-Estrada S, et al (1994) Anabolic effect of human growth hormone: management of inherited disorders of catabolic pathways. Biochem Med Metab Biol 52: 145–154.

    Article  PubMed  CAS  Google Scholar 

  • Matsui SM, Mahoney MJ, Rosenberg LE (1983) The natural history of the inherited methylmalonic acidemias. N Engl J Med 308: 857–861.

    Article  PubMed  CAS  Google Scholar 

  • Ney D, Bay C, Saudubray JM, et al (1985) An evaluation of protein requirements in methylmalonic acidaemia. J Inherit Metab Dis 8: 132–142.

    Article  PubMed  CAS  Google Scholar 

  • 11O Ogier de Baulny H, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM (2005) Methylmalonic and propionic acidaemias: management and outcome. J Inherit Metab Dis 28: 415–423.

    Article  PubMed  CAS  Google Scholar 

  • Roe CR, Hoppel CL, Stacey TE, Chalmers RA, Treacey BM, Millington DS (1983) Metabolic response to carnitine in methylmalonic aciduria: an effective strategy for elimination of propionyl groups. Arch Dis Child 58: 916–920.

    Article  PubMed  CAS  Google Scholar 

  • Sbai D, Narcy C, Thompson GN, et al (1994) Contribution of odd-chain fatty acid oxidation to propionate production in disorders of propionate metabolism. Am J Clin Nutr 59: 1332–1337.

    PubMed  CAS  Google Scholar 

  • Schlenzig JS, Poggi-Travert F, Laurent J, et al (1995) Liver transplantation in two cases of propionic acidaemia. J Inherit Metab Dis 18: 448–461.

    Article  PubMed  CAS  Google Scholar 

  • Sokal EM (2006) Liver transplantation for inborn errors of liver metabolism: a review. J Inherit Metab Dis 29: 426–430.

    PubMed  Google Scholar 

  • Thompson GN, Chalmers RA, Walter JH, et al (1990) The use of metronidazole in management of methylmalonic and propionic acidemias. Eur J Pediatr 149: 792–796.

    Article  PubMed  CAS  Google Scholar 

  • Touati G, Ogier de Baulny H, Rabier D, et al (2003) Beneficial effects of growth hormone treatment in children with methylmalonic and propionic acidurias. J Inherit Metab Dis 26(Supplement 2): 40.

    Google Scholar 

  • Van der Meer S, Poggi F, Spada M, et al (1994) Clinical outcome of long-term management of 26 patients with vitamin B12-unresponsive methylmalonic acidemia. J Pediatr 125: 903–908.

    Article  PubMed  Google Scholar 

  • Van der Meer S, Poggi F, Spada M, et al (1996) Clinical outcome and long-term management of 17 patients with propionic acidaemia. Eur J Pediatr 155: 205–210.

    Article  PubMed  Google Scholar 

  • Walter JH, Thompson GN, Leonard JV, Bartlett K, Halliday K (1989) Contribution of amino acid catabolism to propionate production in methylmalonic acidaemia. Lancet 1: 1298–1299.

    Article  PubMed  CAS  Google Scholar 

  • Yannicelli S (2006) Nutrition therapy of organic acidaemia with amino acid based medical foods: emphasis on metabolic and propionic acidaemias. J Inherit Metab Dis 29: 281–287.

    PubMed  CAS  Google Scholar 

  • Yannicelli S, Acosta PB, Velazquez A, et al (2003) Improved growth and nutrition status in children with methylmalonic or propionic acidemia fed an elemental medical food. Mol Genet Metab 80: 181–188.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Touati.

Additional information

Communicating editor: Jean-Marie Saudubray

Competing interests: None declared

Rights and permissions

Reprints and permissions

About this article

Cite this article

Touati, G., Valayannopoulos, V., Mention, K. et al. Methylmalonic and propionic acidurias: Management without or with a few supplements of specific amino acid mixture. J Inherit Metab Dis 29, 288–298 (2006). https://doi.org/10.1007/s10545-006-0351-7

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-006-0351-7

Keywords

Navigation